Sports
AstraZeneca Q2 Pre-tax Profit Down, But EPS Rise; Backs Positive FY26 View
(RTTNews) - British drug major AstraZeneca PLC reported Monday lower pre-tax pofit in its second quarter mainly on lower tax expenses, while earnings per share grew from last year with higher revenues, excluding weak Ch…